• LAST PRICE
    45.3900
  • TODAY'S CHANGE (%)
    Trending Up0.1800 (0.3981%)
  • Bid / Lots
    44.5000/ 1
  • Ask / Lots
    65.0000/ 5
  • Open / Previous Close
    45.2000 / 45.2100
  • Day Range
    Low 44.3700
    High 47.0800
  • 52 Week Range
    Low 12.4500
    High 67.2100
  • Volume
    273,439
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 45.21
TimeVolumePRAX
09:32 ET57445.2
09:38 ET40045.02
09:39 ET251546
09:43 ET64646.09
09:45 ET186646.5
09:48 ET69546.34
09:50 ET30646.67
09:52 ET100046.01
09:54 ET10045.8
09:57 ET80045.45
09:59 ET40045.32
10:01 ET174944.96
10:06 ET10044.64
10:08 ET69944.5
10:10 ET1899244.37
10:12 ET281544.91
10:15 ET30044.925
10:24 ET10045.255
10:30 ET40045.02
10:33 ET110044.745
10:35 ET10044.66
10:37 ET20044.374
10:42 ET10044.41
10:46 ET10044.42
10:48 ET20044.615
10:50 ET249844.79
10:53 ET10044.64
10:55 ET10044.64
10:57 ET20044.64
11:00 ET24444.64
11:02 ET70044.76
11:04 ET20044.64
11:06 ET20044.635
11:08 ET50044.635
11:09 ET30044.635
11:11 ET20044.635
11:13 ET10044.77
11:15 ET118644.975
11:20 ET20045.11
11:22 ET33045.11
11:24 ET40045.135
11:26 ET10045.24
11:27 ET20045.09
11:29 ET45045.134
11:31 ET20045.2
11:33 ET10045.21
11:36 ET10045.19
11:40 ET272444.8
11:44 ET40044.75
11:47 ET40044.715
11:49 ET1797045.3
11:51 ET1602245.4
11:54 ET100045.55
11:56 ET10045.84
11:58 ET129945.93
12:00 ET20046.01
12:02 ET40046.01
12:03 ET40046.25
12:05 ET49945.92
12:07 ET109746.12
12:09 ET1700846.63
12:12 ET220046.805
12:14 ET30046.805
12:16 ET10046.81
12:18 ET50846.62
12:20 ET80046.605
12:21 ET114546.6
12:25 ET10046.6
12:27 ET10046.6
12:30 ET46146.4
12:34 ET10046.16
12:36 ET10046.16
12:38 ET10046.095
12:39 ET270046.5
12:41 ET120545.92
12:43 ET59945.8
12:48 ET10045.8
12:52 ET10045.735
12:57 ET20045.545
01:03 ET20045.17
01:06 ET10045.3
01:10 ET65145.305
01:12 ET10045.305
01:14 ET10045.305
01:21 ET10045.094
01:28 ET10045.09
01:30 ET20045.09
01:33 ET10045.08
01:35 ET100345.21
01:51 ET161645.2
01:53 ET100045.14
01:57 ET10045.085
02:00 ET110044.725
02:02 ET10044.725
02:04 ET20044.725
02:06 ET10044.6
02:08 ET10044.725
02:09 ET10044.71
02:15 ET10044.71
02:18 ET195545.03
02:20 ET10045
02:24 ET10045
02:27 ET20045
02:31 ET10045
02:36 ET10045
02:40 ET10044.995
02:42 ET10044.995
02:44 ET135945.035
02:45 ET20045.05
02:47 ET20045.05
02:54 ET30045.07
02:56 ET220044.89
03:00 ET10044.9
03:03 ET10044.97
03:05 ET10044.764
03:07 ET27344.752
03:12 ET162945.13
03:16 ET10045.13
03:20 ET40045.24
03:21 ET351145.275
03:23 ET171645.575
03:25 ET30045.81
03:27 ET125745.75
03:30 ET20045.93
03:32 ET50045.7
03:34 ET30045.7
03:36 ET230045.11
03:38 ET76945.34
03:39 ET2923745.095
03:43 ET20045.07
03:45 ET30045.185
03:48 ET222044.96
03:50 ET20044.96
03:52 ET90044.94
03:54 ET160545.065
03:56 ET250845.07
03:57 ET195945.11
03:59 ET567445.39
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRAX
Praxis Precision Medicines Inc
773.4M
-2.9x
---
United StatesDNTH
Dianthus Therapeutics Inc
770.4M
-8.0x
---
United StatesHLVX
Hillevax Inc
774.2M
-4.8x
---
United StatesHUMA
Humacyte Inc
764.5M
-6.3x
---
United StatesALXO
ALX Oncology Holdings Inc
763.8M
-3.8x
---
United StatesIRON
Disc Medicine Inc
789.1M
-9.5x
---
As of 2024-05-17

Company Information

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, is an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include ulixacaltamide, PRAX-562, PRAX-628 and elsunersen.

Contact Information

Headquarters
99 High Street, 30th FloorBOSTON, MA, United States 02110
Phone
617-300-8460
Fax
302-655-5049

Executives

Independent Chairman of the Board
Dean Mitchell
President, Chief Executive Officer, Director
Marcio Souza
Chief Financial Officer
Timothy Kelly
General Counsel, Corporate Secretary
Alex Nemiroff
Independent Director
Jeffrey Chodakewitz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$773.4M
Revenue (TTM)
$2.2M
Shares Outstanding
17.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.77
EPS
$-15.91
Book Value
$7.92
P/E Ratio
-2.9x
Price/Sales (TTM)
352.4
Price/Cash Flow (TTM)
---
Operating Margin
-5,930.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.